TCM
ENFN

TimesSquare Capital Management’s Enfusion, Inc. ENFN Stock Holding History

TimesSquare Capital Management’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,643,505
Closed -$16.8M – 198
2022
Q2 		$16.8M Buy
1,643,505
+12,200
+0.7% +$135K 0.23% 148
2022
Q1 		$20.8M Buy
1,631,305
+131,280
+9% +$2.01M 0.23% 149
2021
Q4 		$31.4M Buy
+1,500,025
New +$30.3M 0.28% 145

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $514M AUM 4.45% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $2.83B AUM 12.55% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
ACM
Ararat Capital Management Westport, Connecticut $213M AUM 42.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

TimesSquare Capital Management's ENFN Position: Q3 2022 in Review

TimesSquare Capital Management sold out of Enfusion, Inc. (ENFN) in Q3 2022, closing a stake of 1,643,505 shares — an estimated $16.8M sold.

TimesSquare Capital Management first reported a position in ENFN in Q4 2021 and held it in 3 quarters. The position peaked at $31.4M in Q4 2021. 67 funds tracked by Wall St. Rank hold ENFN as of Q3 2022.

  • TimesSquare Capital Management reported no remaining Enfusion, Inc. position as of Q3 2022 after selling out during the quarter.
  • TimesSquare Capital Management sold 1,643,505 Enfusion, Inc. shares in Q3 2022, an estimated $16.8M.
  • TimesSquare Capital Management first reported a position in Enfusion, Inc. in Q4 2021 and held it in 3 quarters.
  • TimesSquare Capital Management's Enfusion, Inc. position peaked at $31.4M in Q4 2021.
  • 67 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q3 2022.

Based on TimesSquare Capital Management's 13F filing for Q3 2022, filed 9 Nov 2022.